Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02032719
Other study ID # 2012-259
Secondary ID
Status Recruiting
Phase Phase 3
First received January 6, 2014
Last updated January 9, 2014
Start date January 2013
Est. completion date June 2014

Study information

Verified date January 2014
Source York University
Contact Paul Ritvo, PhD
Phone 4165808021
Email pritvo@yorku.ca
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Patients who receive smartphone-assisted health coaching will have a significantly lower 24 hour ambulatory blood pressure mean than patients who receive just health coaching


Description:

Primary Outcome Measure: Mean 24 hour ambulatory blood pressure

Secondary Outcome Measures: Profile of Mood States-SF Vigor Scale; Satisfaction with Life Scale; Positive and Negative Affect Schedule; Hospital Anxiety and Depression Scale; SF - 12


Recruitment information / eligibility

Status Recruiting
Enrollment 65
Est. completion date June 2014
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender Both
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria:

- 25 - 70 years old;

- mean daytime systolic BP> 130 mm. Hg.

Exclusion Criteria:

- Severe or end-stage organ disease (liver, kidney, heart, lung) or history of diabetic ketoacidosis, or any other illness with expected survival less than 1 year;

- severe cognitive impairment;

- diagnosed psychiatric illness or disability;

- clinical significant cardiac arrhythmia;

- symptomatic orthostatic hypertension;

- pregnancy;

- not fluent in english.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
smartphone-assisted health coaching
smartphone with software provides self monitoring of exercise, diet and stress reduction; provision of timely reminders; photo-journaling of meals; secure text messaging
Lifestyle counseling
Lifestyle counseling

Locations

Country Name City State
Canada Southlake Regional Health Centre Newmarket Ontario

Sponsors (1)

Lead Sponsor Collaborator
York University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary 24 hour ambulatory blood pressure mean 24 hour ambulatory blood pressure assessed at baseline and 6 months follow up in experimental and control groups 6 months follow up from baseline No
Secondary Quality of life self report measures Profile of Mood States - SF Vigor Scale Satisfaction with Life Scale Positive and Negative Affect Schedule Hospital Anxiety and Depression Scale; SF 12 Baseline and 6 months followup No
See also
  Status Clinical Trial Phase
Recruiting NCT05086523 - Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study Phase 1/Phase 2
Completed NCT00151229 - Valsartan in Elderly Isolated Systolic Hypertension Study Phase 4
Recruiting NCT04755764 - Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Completed NCT03712033 - TEC4Home Stroke - Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA Patients
Completed NCT00940966 - A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome N/A
Recruiting NCT06084065 - Feasibility and Effectiveness of a Ring-type Blood Pressure Measurement Device N/A
Completed NCT01755572 - Blood Pressure Outcomes With Liraglutide Therapy Phase 4
Completed NCT01281306 - An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension Phase 2